Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma

He, Y; Lin, WC; Cai, ZJ; Huang, YF; You, MJ; Lei, MS; Chen, RJ

Lei, MS (通讯作者),Fujian Med Univ, Mindong Hosp, Dept Pharm, Ningde, Fujian, Peoples R China.;Chen, RJ (通讯作者),Fujian Med Univ, Mengchao Hepatobiliary Hosp, Dept Pharm, Fuzhou 350025, Fujian, Peoples R China.

FRONTIERS IN PHARMACOLOGY, 2023; 14 ():

Abstract

Purpose: Results from the LAUNCH trial suggest transarterial chemoembolization (TACE) in combination with lenvatinib is significantly more effective t......

Full Text Link